Viridian Therapeutics, Inc. earnings per share and revenue

VRDN earnings per share for the last quarter are -1.02 USD whereas the estimation was -0.87 USD which accounts for -17.14% surprise. Company revenue for the same period amounts to 72.00 k USD despite the estimated figure of 78.15 k USD. Estimated earnings per share for the next quarter are -1.06 USD, and revenue is expected to reach 91.00 k USD. Also watch annual changes over time to get a bigger picture of VRDN earnings per share and revenue dynamics.